Bicentric Clinical Investigation to Assess Safety and Performance of LuxBoost IOL
ConditionAphakia
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50+
SponsorCutting Edge SAS
About this trial
The study purpose is to demonstrate safety and performance of bilateral implantation of LuxBoost intraocular lenses compared with the LuxGood Monofocal lens.
Eligibility criteria
Qualifiers
Subject aged 50 or over on the day of inclusion, presenting a
bilateral cataract for which posterior chamber IOL implantation
has been planned.
Fit within the available IOL diopter range.
Disqualifiers
Ocular surface disease potentially affecting study results
Subjects suffering from diagnosed degenerative visual disorders
Pre-existing ocular pathology
Acute or chronic disease or illness that would increase risk or confound study results
Trial design
Treatments tested in this trial
- LuxBoost IOL
- LuxGood IOL
Treatment groups
58 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov